Literature DB >> 3924030

[14C]bicarbonate fixation into glucose and other metabolites in the liver of the starved rat under halothane anaesthesia. Metabolic channelling of mitochondrial oxaloacetate.

D F Heath, J G Rose.   

Abstract

Previous attempts to account for the labelling in vivo of liver metabolites associated with the citrate cycle and gluconeogenesis have foundered because proper allowance was not made for the heterogeneity of the liver. In the basal state (anaesthetized after 24h starvation) this heterogeneity is minimal, and we show that labelling by [14C]bicarbonate can be interpreted unambiguously. [14C]Bicarbonate was infused to an isotopic steady state, and measurements were made of specific radioactivities of blood bicarbonate, alanine, glycerol and lactate, of liver alanine and lactate, and of individual carbon atoms in blood glucose and liver aspartate, citrate and malate. (Existing methods for several of these measurements were extensively modified.) The results were combined with published rates of gluconeogenesis, uptake of gluconeogenic precursors by the liver, and citrate-cycle flux, all measured under similar conditions, and with estimates of other rates made from published data. To interpret the results, three ancillary measurements were made: the rate of CO2 exchange by phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32) under conditions that simulated those in vivo; the 14C isotope effect in the pyruvate carboxylase (EC 6.4.1.1) reaction (14C/12C = 0.992 +/- 0.008; S.E.M., n = 8); the ratio of labelling by [2-14C]- to that by [1-14C]-pyruvate of liver glutamate 1.5 min after injection. This ratio, 3.38, is a measure of the disequilibrium in the mitochondria between malate and oxaloacetate. The data were analysed with due regard to experimental variance, uncertainties in values of fluxes measured in vitro, hepatic heterogeneity and renal glucose output. The following conclusions were reached. The results could not be explained if CO2 fixation was confined to pyruvate carboxylase and there was only one, well-mixed, pool of oxaloacetate in the mitochondria. Addition of the other carboxylation reactions, those of PEPCK, isocitrate dehydrogenase (EC 1.1.1.42) and malic enzyme (EC 1.1.1.40), was not enough. Incomplete mixing of mitochondrial oxaloacetate had to be assumed, i.e. that there was metabolic channelling of oxaloacetate formed from pyruvate towards gluconeogenesis. There was some evidence that malate exchange across the mitochondrial membrane might also be channelled, with incomplete mixing with that in the citrate cycle. Calculated rates of exchange of CO2 by PEPCK were in agreement with those measured in vitro, with little or no activation by Fe2+ ions.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924030      PMCID: PMC1144914          DOI: 10.1042/bj2270851

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  68 in total

1.  [New values for the molar extinction coefficients of NADH and NADPH for the use in routine laboratories (author's transl)].

Authors:  H U Bergmeyer
Journal:  Z Klin Chem Klin Biochem       Date:  1975-11

2.  A simple enzymic determination of the specific 14 C (1) -labelling of 6-phosphogluconate, glucose 6-phosphate, fructose 6-phosphate and glucose.

Authors:  K Lange; K Keller; H Kolbe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  Net renal glucose release in the rat.

Authors:  P C Churchill; F L Belloni; M C Churchill
Journal:  Am J Physiol       Date:  1973-09

4.  Gluconeogenesis and amino acid metabolism. II. Inter-organal relations and roles of glutamine and alanine in the amino acid metabolism of fasted rats.

Authors:  T Aikawa; H Matsutaka; H Yamamoto; T Okuda; E Ishikawa
Journal:  J Biochem       Date:  1973-11       Impact factor: 3.387

5.  Regulation of gluconeogenesis and lipogenesis. Inhibition of pyruvate carboxylation in rat kidney mitochondria by malonate and malonyl CoA.

Authors:  M A Mehlman; P Walter
Journal:  Arch Biochem Biophys       Date:  1968-09-20       Impact factor: 4.013

6.  Activation and inactivation of phosphoenolpyruvate carboxykinase by ferrous ions.

Authors:  C H Reynolds
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

7.  Disequilibrium in the malate dehydrogenase reaction in rat liver mitochondria in vivo.

Authors:  D F Heath; J C Phillips
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

8.  Hemodynamic and metabolic responses to repeated blood sampling in the rat.

Authors:  G M Walsh; R A Ferrone; M Tsuchiya; E F Woods; E C Deland
Journal:  Am J Physiol       Date:  1980-12

9.  Renal gluconeogenesis: axial and internephron heterogeneity and the effect of parathyroid hormone.

Authors:  M S Wang; K Kurokawa
Journal:  Am J Physiol       Date:  1984-01

10.  Renal net glucose release in vivo and its contribution to blood glucose in rats.

Authors:  K Kida; S Nakajo; F Kamiya; Y Toyama; T Nishio; H Nakagawa
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  4 in total

1.  The effects of stress and injury on the activity of phosphoenolpyruvate carboxykinase in the liver of the rat.

Authors:  J G Rose; D F Heath
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

2.  Quantitative analysis of intermediary metabolism in rat hepatocytes incubated in the presence and absence of ethanol with a substrate mixture including ketoleucine.

Authors:  J M Baranyai; J J Blum
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

3.  Dicarboxylic acid fluxes during gluconeogenesis. No channelling of mitochondrial oxalacetate.

Authors:  R Rognstad
Journal:  Bull Math Biol       Date:  1995-07       Impact factor: 1.758

4.  Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy.

Authors:  Douglas E Befroy; Rachel J Perry; Nimit Jain; Sylvie Dufour; Gary W Cline; Jeff K Trimmer; Julia Brosnan; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.